Log in
Enquire now

List of Quest PharmaTech patents

List of Quest PharmaTech patents
List of Anutra Medical patents
List of Clearslide (company) patents
List of Metabolic Solutions Development Company patents
Founders educated at Bryant University
List of companies in Puget Sound Venture Club's investment portfolio
Patents where
Current Assignee
Name
is
Quest PharmaTechQuest PharmaTech
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 8758725 Perylenequinone derivatives and uses thereof

Patent 8758725 was granted and assigned to Quest PharmaTech on June, 2014 by the United States Patent and Trademark Office.

Quest PharmaTech
Quest PharmaTech
Quest PharmaTech
Quest PharmaTech
United States Patent and Trademark Office
United States Patent and Trademark Office
8758725
June 24, 2014
‌
US Patent 8747811 Perylenequinone derivatives and uses thereof

Patent 8747811 was granted and assigned to Quest PharmaTech on June, 2014 by the United States Patent and Trademark Office.

Quest PharmaTech
Quest PharmaTech
Quest PharmaTech
Quest PharmaTech
United States Patent and Trademark Office
United States Patent and Trademark Office
8747811
June 10, 2014
‌
US Patent 8038994 Combination therapy for treating disease

Patent 8038994 was granted and assigned to Quest PharmaTech on October, 2011 by the United States Patent and Trademark Office.

Quest PharmaTech
Quest PharmaTech
United States Patent and Trademark Office
United States Patent and Trademark Office
8038994
October 18, 2011
‌
US Patent 8916205 Polymeric nanoparticles for photosensitizers

Patent 8916205 was granted and assigned to Quest PharmaTech on December, 2014 by the United States Patent and Trademark Office.

Quest PharmaTech
Quest PharmaTech
United States Patent and Trademark Office
United States Patent and Trademark Office
8916205
December 23, 2014
‌
US Patent 8506931 Perylenequinone derivatives and uses thereof

Quest PharmaTech
Quest PharmaTech
United States Patent and Trademark Office
United States Patent and Trademark Office
8506931
August 13, 2013
‌
US Patent 11773183 MUC16 monoclonal antibody and uses thereof

Patent 11773183 was granted and assigned to Quest PharmaTech on October, 2023 by the United States Patent and Trademark Office.

Quest PharmaTech
Quest PharmaTech
Quest PharmaTech
Quest PharmaTech
United States Patent and Trademark Office
United States Patent and Trademark Office
11773183
October 3, 2023
6 results
0 selected
6 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us